Orchestra BioMed Announces Clinical Data Demonstrating a Significant and Sustained Reduction in Blood Pressure in MODERATO II Control Patients After Crossover to BackBeat Cardiac Neuromodulation Therapy
Data Shows BackBeat CNT Reduces Blood Pressure in Crossover Hypertensive Patients Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”),…
Valencell Expands World’s First Calibration-Free, Cuffless Blood Pressure Monitoring System to the Finger and Wrist
National survey finds 75% of those managing hypertension would measure heart vitals more often with passive monitoring devices Valencell,…
Hello Heart, a Leading Digital Heart Health Solution, Announces Series B Financing led by Khosla Ventures
Hello Heart, a leading digital hypertension program, completed a $12M Series B led by Khosla Ventures, adding to Khosla’s…